Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

MLA

A.H. Jan Danser, et al. “Genomic and Nongenomic Effects of Aldosterone in the Rat Heart: Why Is Spironolactone Cardioprotective?” British Journal of Pharmacology, vol. 145, July 2005, pp. 664–71. EBSCOhost, https://doi.org/10.1038/sj.bjp.0706220.

APA

A.H. Jan Danser, Jos M. J. Lamers, Ingrid M. Garrelds, Wenxia Chai, Udayasankar Arulmani, & Regien G. Schoemaker. (2005). Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective? British Journal of Pharmacology, 145, 664–671. https://doi.org/10.1038/sj.bjp.0706220

Chicago

A.H. Jan Danser, Jos M. J. Lamers, Ingrid M. Garrelds, Wenxia Chai, Udayasankar Arulmani, and Regien G. Schoemaker. 2005. “Genomic and Nongenomic Effects of Aldosterone in the Rat Heart: Why Is Spironolactone Cardioprotective?” British Journal of Pharmacology 145 (July): 664–71. doi:10.1038/sj.bjp.0706220.